TABLE 5

Reported Dosages for the 2 Hypothetical Patients According to Familiarity of Site with 2010 Guidelines

Respondents (n)Respondents following guideline ± 20%
AgentTotalYesNoTotalYesNoGuideline-recommended dosage*
Boy
 99mTc-MDP50261866.0%88.5%38.9%185.0 (5)
 99mTc-MAG342271245.2%55.6%25.0%111.0 (3)
 99mTc-DMSA37231254.1%69.6%25.0%37.0 (1)
 99mTc-HIDAs27151048.2%73.3%10.0%37.0 (1)
 18F-FDG2014570.0%78.6%60.0%74.0–103.6 (2.0–2.8)
Girl
 99mTc-MDP50261850.0%84.6%44.4%277.5 (7.5)
 99mTc-MAG343271245.2%55.6%25.0%166.5 (4.5)
 99mTc-DMSA37231251.4%65.2%33.3%55.5 (1.5)
 99mTc-HIDAs27151040.7%73.3%10.0%55.5 (1.5)
 18F-FDG2014570.0%85.7%60.0%111.0–155.4 (3.0–4.2)
  • * Units of measurement are megabecquerels (MBq) followed by millicuries (mCi) in parentheses.

  • The hypothetical patients are a 5-y-old, 20-kg, 110-cm boy and a 10-y-old, 30-kg, 140-cm girl.